XERS - Xeris Biopharma Holdings, Inc.
IEX Last Trade
2.9
0 0%
Share volume: 304,478
Last Updated: Tue 24 Dec 2024 04:30:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$2.90
0.53
0.15%
Summary score
30%
Profitability
15%
Dept financing
25%
Liquidity
75%
Performance
35%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.58%
Return on assets
-8.62%
Return on sales
-182.87%
Return on invested capital
23.19%
Total debt ratio
87.11%
Debt ratio change over timeo
-3.16%
Current Ratio
3.32%
Quick Ratio
2.97%
Cash Position Ratio
2.38%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.15%
Return on assets
-3.41%
Return on sales
-27.36%
Return on invested capital
-18.96%
Total debt ratio
99.88%
Debt ratio change over timeo
-4.96%
Current Ratio
1.95%
Quick Ratio
1.48%
Cash Position Ratio
0.93%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
206.8%
Return on assets
-4.23%
Return on sales
-35.05%
Return on invested capital
-21.03%
Total debt ratio
102.73%
Debt ratio change over time
-6.46%
Current Ratio
2.37%
Quick Ratio
1.81%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-172.71%
Return on assets
-88.01%
Return on sales
-10.73%
Return on invested capital
-15.58%
Total debt ratio
-315.64%
Debt ratio change over time
-3.16%
Current Ratio
-5.35%
Quick Ratio
-4.47%
Cash Position Ratio
-3.25%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XERS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 18.58% | 18.83% | 17.34% | 7.6% |
| Return on assets | -8.62% | 4.16% | 8.21% | 3.22% |
| Return on sales | -182.87% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 23.19% | 9.79% | -219.55% | 7.46% |
| Profitability | 50% | 65% | 73% | 43% |
| Total debt ratio | 87.11% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -3.16% | -4.38% | -0.73% | -33.74% |
| Dept financing | 25% | 24% | 41% | 17% |
| Current Ratio | 1.95% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.48% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 0.93% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 19% | 19% | 25% |
| Short-term ratios | XERS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -14.15% | 13.31% | 0% | 13.48% |
| Return on assets | -3.41% | 4.72% | 0% | 3.05% |
| Return on sales | -27.36% | 31.4% | 0% | 25.56% |
| Return on invested capital | -18.96% | 10.68% | 0% | 13.96% |
| Profitability | 0% | 94% | 0% | 87% |
| Total debt ratio | 99.88% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -4.96% | -41.82% | 0% | 7.13% |
| Dept financing | 25% | 20% | 0% | 40% |
| Current Ratio | 1.95% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.48% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 0.93% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 32% | 0% | 44% |